News Sentiment

AGY sentiment intelligence

Allergy Therapeutics plc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 7 relevant articles
Exchange LSE United Kingdom
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 0.07 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

82/100 classification confidence.

Company focus 7

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+1.8% over one week, -14.9% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Enterprise value to EBIT forward of Allergy Therapeutics plc – LSE:AGY

Market Reaction

Balanced read

67/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 82/100 classification
One-week reaction 1.8% Price digesting
Trend fit Trend inactive -14.9% over four weeks
Fair value 9.8% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 3
Neutral 4
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 7
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 1
Market source 1
simplywall.st 1
DirectorsTalk Interviews 1
Labiotech.eu 1
marketexclusive.com 1
This is Money 1

Event Lens

What the news is about

Classified themes
Market update 6
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-7 of 7